Global Breast Biopsy Devices Market Growth 2025-2031

The global Breast Biopsy Devices market size is predicted to grow from US$ 626 million in 2025 to US$ 1225 million in 2031; it is expected to grow at a CAGR of 11.8% from 2025 to 2031.

Breast Biopsy is a procedure in which a sample of a suspicious breast growth is removed and examined, usually for the presence of cancer. The sample is suctioned out through a needle or removed surgically. A breast biopsy is the best way to evaluate if a suspicious lump or portion of your breast is cancerous. Breast Biopsy Devices means include biopsy needles, biopsy tables, localization wires, guidance systems and others.

Global Breast Biopsy Devices key players include Mammotome, Hologic, C.R Bard, BD, etc. North America is the largest market, with a share over 50%, followed by Europe, which has a share over 25 percent. In terms of product, Guidance Systems is the largest segment, with a share over 30%. In terms of application, Hospital is the largest market, with a share over 70%.

LP Information, Inc. (LPI) ' newest research report, the “Breast Biopsy Devices Industry Forecast” looks at past sales and reviews total world Breast Biopsy Devices sales in 2024, providing a comprehensive analysis by region and market sector of projected Breast Biopsy Devices sales for 2025 through 2031. With Breast Biopsy Devices sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Breast Biopsy Devices industry.

This Insight Report provides a comprehensive analysis of the global Breast Biopsy Devices landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Breast Biopsy Devices portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Breast Biopsy Devices market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Breast Biopsy Devices and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Breast Biopsy Devices.

This report presents a comprehensive overview, market shares, and growth opportunities of Breast Biopsy Devices market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Biopsy Needles
Biopsy Tables
Guidance Systems
Localization Wires
Others

Segmentation by Application:
Hospital
Clinic

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Mammotome
Hologic
C.R Bard
BD
Stryker
Galini SRL
Medtronic
Izi Medical Products
Trivitron
Scion Medical

Key Questions Addressed in this Report

What is the 10-year outlook for the global Breast Biopsy Devices market?

What factors are driving Breast Biopsy Devices market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Breast Biopsy Devices market opportunities vary by end market size?

How does Breast Biopsy Devices break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.